{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:56Z","timestamp":1792783196380,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T00:00:00Z","timestamp":1463529600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["He 2526\/6-2"],"award-info":[{"award-number":["He 2526\/6-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GK1045"],"award-info":[{"award-number":["GK1045"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001656","name":"Helmholtz-Gemeinschaft","doi-asserted-by":"publisher","award":["VISTRIE VH-VI-242"],"award-info":[{"award-number":["VISTRIE VH-VI-242"]}],"id":[{"id":"10.13039\/501100001656","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["QLRT-2001-01112"],"award-info":[{"award-number":["QLRT-2001-01112"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["MRTN-CT-2005-019248"],"award-info":[{"award-number":["MRTN-CT-2005-019248"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German Academic Exchange Service (DE)","award":["A\/02\/11462"],"award-info":[{"award-number":["A\/02\/11462"]}],"id":[{"id":"https:\/\/ror.org\/039djdh30","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005298","name":"Universidad de Costa Rica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005298","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00430-016-0457-y","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T11:31:42Z","timestamp":1463571102000},"page":"409-424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Highly individual patterns of virus-immune IgG effector responses in humans"],"prefix":"10.1007","volume":"205","author":[{"given":"Eugenia","family":"Corrales-Aguilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Trilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Reinhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ortwin","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Santibanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Hengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"key":"457_CR1","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nri891","volume":"2","author":"DR Burton","year":"2002","unstructured":"Burton DR (2002) Antibodies, viruses and vaccines. Nat Rev Immunol 2:706\u2013713. doi: 10.1038\/nri891","journal-title":"Nat Rev Immunol"},{"key":"457_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0022-1759(85)90044-4","volume":"77","author":"B Friguet","year":"1985","unstructured":"Friguet B, Chaffotte AF, Djavadi-Ohaniance L, Goldberg ME (1985) Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Methods 77:305\u2013319. doi: 10.1016\/0022-1759(85)90044-4","journal-title":"J Immunol Methods"},{"key":"457_CR3","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","volume":"186","author":"K Bakkouri El","year":"2011","unstructured":"El Bakkouri K, Descamps F, De Filette M et al (2011) Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection. J Immunol 186:1022\u20131031. doi: 10.4049\/jimmunol.0902147","journal-title":"J Immunol"},{"key":"457_CR4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0092-8674(90)90464-P","volume":"61","author":"WG Laver","year":"1990","unstructured":"Laver WG, Air GM, Webster RG, Smith-Gill SJ (1990) Epitopes on protein antigens: misconceptions and realities. Cell 61:553\u2013556","journal-title":"Cell"},{"key":"457_CR5","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","volume":"172","author":"A Jegerlehner","year":"2004","unstructured":"Jegerlehner A, Schmitz N, Storni T, Bachmann MF (2004) Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol 172:5598\u20135605","journal-title":"J Immunol"},{"key":"457_CR6","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","volume":"181","author":"DM Carragher","year":"2008","unstructured":"Carragher DM, Kaminski DA, Moquin A et al (2008) A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. J Immunol 181:4168\u20134176. doi: 10.4049\/jimmunol.181.6.4168","journal-title":"J Immunol"},{"key":"457_CR7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/1570162X113116660058","volume":"11","author":"ME Ackerman","year":"2013","unstructured":"Ackerman ME, Alter G (2013) Opportunities to exploit non-neutralizing HIV-specific antibody activity. Curr HIV Res 11:365\u2013377","journal-title":"Curr HIV Res"},{"key":"457_CR8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/CDLI.2.2.214-218.1995","volume":"2","author":"J Zanten van","year":"1995","unstructured":"van Zanten J, Harmsen MC, van der Giessen M et al (1995) Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteins. Clin Diagn Lab Immunol 2:214\u2013218","journal-title":"Clin Diagn Lab Immunol"},{"key":"457_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1600-065X.2010.00910.x","volume":"236","author":"F Nimmerjahn","year":"2010","unstructured":"Nimmerjahn F, Ravetch JV (2010) Antibody-mediated modulation of immune responses. Immunol Rev 236:265\u2013275. doi: 10.1111\/j.1600-065X.2010.00910.x","journal-title":"Immunol Rev"},{"issue":"Pt 1","key":"457_CR10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1099\/0022-1317-72-1-149","volume":"72","author":"HE Farrell","year":"1991","unstructured":"Farrell HE, Shellam GR (1991) Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies. J Gen Virol 72(Pt 1):149\u2013156","journal-title":"J Gen Virol"},{"key":"457_CR11","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1182\/blood-2007-06-095414","volume":"110","author":"K Klenovsek","year":"2007","unstructured":"Klenovsek K, Weisel F, Schneider A et al (2007) Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells. Blood 110:3472\u20133479. doi: 10.1182\/blood-2007-06-095414","journal-title":"Blood"},{"key":"457_CR12","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/eji.201343566","volume":"43","author":"K Richter","year":"2013","unstructured":"Richter K, Oxenius A (2013) Non-neutralizing antibodies protect from chronic LCMV infection independently of activating Fc\u03b3R or complement. Eur J Immunol 43:2349\u20132360. doi: 10.1002\/eji.201343566","journal-title":"Eur J Immunol"},{"key":"457_CR13","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/eji.201343565","volume":"43","author":"T Straub","year":"2013","unstructured":"Straub T, Schweier O, Bruns M et al (2013) Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and Fc\u03b3R. Eur J Immunol 43:2338\u20132348. doi: 10.1002\/eji.201343565","journal-title":"Eur J Immunol"},{"issue":"Pt 12","key":"457_CR14","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1099\/0022-1317-78-12-3227","volume":"78","author":"CD Partidos","year":"1997","unstructured":"Partidos CD, Ripley J, Delmas A et al (1997) Fine specificity of the antibody response to a synthetic peptide from the fusion protein and protection against measles virus-induced encephalitis in a mouse model. J Gen Virol 78(Pt 12):3227\u20133232","journal-title":"J Gen Virol"},{"key":"457_CR15","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1099\/vir.0.014266-0","volume":"90","author":"DE Wright","year":"2009","unstructured":"Wright DE, Colaco S, Colaco C, Stevenson PG (2009) Antibody limits in vivo murid herpesvirus-4 replication by IgG Fc receptor-dependent functions. J Gen Virol 90:2592\u20132603. doi: 10.1099\/vir.0.014266-0","journal-title":"J Gen Virol"},{"key":"457_CR16","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.cell.2014.08.023","volume":"158","author":"S Bournazos","year":"2014","unstructured":"Bournazos S, Klein F, Pietzsch J et al (2014) Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity. Cell 158:1243\u20131253. doi: 10.1016\/j.cell.2014.08.023","journal-title":"Cell"},{"key":"457_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nm.3443","volume":"20","author":"DJ DiLillo","year":"2014","unstructured":"DiLillo DJ, Tan GS, Palese P, Ravetch JV (2014) Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo. Nat Med 20:143\u2013151. doi: 10.1038\/nm.3443","journal-title":"Nat Med"},{"key":"457_CR18","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.4049\/jimmunol.1201574","volume":"190","author":"S Jegaskanda","year":"2013","unstructured":"Jegaskanda S, Job ER, Kramski M et al (2013) Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies. J Immunol 190:1837\u20131848. doi: 10.4049\/jimmunol.1201574","journal-title":"J Immunol"},{"key":"457_CR19","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1084\/jem.20151267","volume":"212","author":"S Bournazos","year":"2015","unstructured":"Bournazos S, DiLillo DJ, Ravetch JV (2015) The role of Fc-Fc\u03b3R interactions in IgG-mediated microbial neutralization. J Exp Med 212:1361\u20131369. doi: 10.1084\/jem.20151267","journal-title":"J Exp Med"},{"key":"457_CR20","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3390\/v1031265","volume":"1","author":"V Holl","year":"2009","unstructured":"Holl V, Peressin M, Moog C (2009) Antibody-mediated Fc\u03b3 receptor-based mechanisms of HIV inhibition: recent findings and new vaccination strategies. Viruses 1:1265\u20131294. doi: 10.3390\/v1031265","journal-title":"Viruses"},{"key":"457_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.immunol.19.1.275","volume":"19","author":"JV Ravetch","year":"2001","unstructured":"Ravetch JV, Bolland S (2001) IgG Fc receptors. Annu Rev Immunol 19:275\u2013290. doi: 10.1146\/annurev.immunol.19.1.275","journal-title":"Annu Rev Immunol"},{"key":"457_CR22","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","volume":"119","author":"P Bruhns","year":"2012","unstructured":"Bruhns P (2012) Properties of mouse and human IgG receptors and their contribution to disease models. Blood 119:5640\u20135649. doi: 10.1182\/blood-2012-01-380121","journal-title":"Blood"},{"key":"457_CR23","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","volume":"113","author":"P Bruhns","year":"2009","unstructured":"Bruhns P, Iannascoli B, England P et al (2009) Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 113:3716\u20133725. doi: 10.1182\/blood-2008-09-179754","journal-title":"Blood"},{"key":"457_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2005.11.010","volume":"24","author":"F Nimmerjahn","year":"2006","unstructured":"Nimmerjahn F, Ravetch JV (2006) Fcgamma receptors: old friends and new family members. Immunity 24:19\u201328. doi: 10.1016\/j.immuni.2005.11.010","journal-title":"Immunity"},{"key":"457_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0065-2776(07)96005-8","volume":"96","author":"F Nimmerjahn","year":"2007","unstructured":"Nimmerjahn F, Ravetch JV (2007) Fc-receptors as regulators of immunity. Adv Immunol 96:179\u2013204. doi: 10.1016\/S0065-2776(07)96005-8","journal-title":"Adv Immunol"},{"key":"457_CR26","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.157.5.2168","volume":"157","author":"LL Baum","year":"1996","unstructured":"Baum LL, Cassutt KJ, Knigge K et al (1996) HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. J Immunol 157:2168\u20132173","journal-title":"J Immunol"},{"key":"457_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jri.2007.08.004","volume":"78","author":"C-F Chu","year":"2008","unstructured":"Chu C-F, Meador MG, Young CG et al (2008) Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms. J Reprod Immunol 78:58\u201367. doi: 10.1016\/j.jri.2007.08.004","journal-title":"J Reprod Immunol"},{"key":"457_CR28","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","volume":"166","author":"VC Huber","year":"2001","unstructured":"Huber VC, Lynch JM, Bucher DJ et al (2001) Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections. J Immunol 166:7381\u20137388","journal-title":"J Immunol"},{"key":"457_CR29","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/QAD.0b013e328329f97d","volume":"23","author":"O Lambotte","year":"2009","unstructured":"Lambotte O, Ferrari G, Moog C et al (2009) Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers. AIDS 23:897\u2013906. doi: 10.1097\/QAD.0b013e328329f97d","journal-title":"AIDS"},{"key":"457_CR30","first-page":"187","volume":"65","author":"KC McCullough","year":"1988","unstructured":"McCullough KC, Parkinson D, Crowther JR (1988) Opsonization-enhanced phagocytosis of foot-and-mouth disease virus. Immunology 65:187\u2013191","journal-title":"Immunology"},{"key":"457_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature06106","volume":"449","author":"AJ Hessell","year":"2007","unstructured":"Hessell AJ, Hangartner L, Hunter M et al (2007) Fc receptor but not complement binding is important in antibody protection against HIV. Nature 449:101\u2013104. doi: 10.1038\/nature06106","journal-title":"Nature"},{"key":"457_CR32","doi-asserted-by":"publisher","first-page":"11521","DOI":"10.1128\/JVI.01023-12","volume":"86","author":"M Bonsignori","year":"2012","unstructured":"Bonsignori M, Pollara J, Moody MA et al (2012) Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family. J Virol 86:11521\u201311532. doi: 10.1128\/JVI.01023-12","journal-title":"J Virol"},{"key":"457_CR33","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1128\/JVI.02868-14","volume":"89","author":"M Veillette","year":"2015","unstructured":"Veillette M, Coutu M, Richard J et al (2015) The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals. J Virol 89:545\u2013551. doi: 10.1128\/JVI.02868-14","journal-title":"J Virol"},{"key":"457_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/imm.12232","volume":"142","author":"GK Lewis","year":"2014","unstructured":"Lewis GK (2014) Role of Fc-mediated antibody function in protective immunity against HIV-1. Immunology 142:46\u201357. doi: 10.1111\/imm.12232","journal-title":"Immunology"},{"key":"457_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jim.2012.09.006","volume":"387","author":"E Corrales-Aguilar","year":"2013","unstructured":"Corrales-Aguilar E, Trilling M, Reinhard H et al (2013) A novel assay for detecting virus-specific antibodies triggering activation of Fc\u03b3 receptors. J Immunol Methods 387:21\u201335. doi: 10.1016\/j.jim.2012.09.006","journal-title":"J Immunol Methods"},{"key":"457_CR36","first-page":"1401","volume-title":"Fields virol","author":"DE Griffin","year":"2001","unstructured":"Griffin DE (2001) Measles virus. In: Knipe D, Howley P (eds) Fields virol. Lippincott, Wlliams & Wilkins, Philadelphia, pp 1401\u20131441"},{"key":"457_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jviromet.2005.08.001","volume":"131","author":"BJ Cohen","year":"2006","unstructured":"Cohen BJ, Parry RP, Doblas D et al (2006) Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay. J Virol Methods 131:209\u2013212. doi: 10.1016\/j.jviromet.2005.08.001","journal-title":"J Virol Methods"},{"key":"457_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-016-0451-4","author":"H Holzmann","year":"2016","unstructured":"Holzmann H, Hengel H, Tenbusch M, Doerr HW (2016) Eradication of measles: remaining challenges. Med Microbiol Immunol. doi: 10.1007\/s00430-016-0451-4","journal-title":"Med Microbiol Immunol"},{"key":"457_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00430-015-0388-z","volume":"204","author":"S Plotkin","year":"2015","unstructured":"Plotkin S (2015) The history of vaccination against cytomegalovirus. Med Microbiol Immunol 204:247\u2013254. doi: 10.1007\/s00430-015-0388-z","journal-title":"Med Microbiol Immunol"},{"key":"457_CR40","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/cid\/cis238","volume":"54","author":"SA Plotkin","year":"2012","unstructured":"Plotkin SA, Gilbert PB (2012) Nomenclature for immune correlates of protection after vaccination. Clin Infect Dis 54:1615\u20131617. doi: 10.1093\/cid\/cis238","journal-title":"Clin Infect Dis"},{"issue":"Pt 12","key":"457_CR41","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1099\/0022-1317-76-12-2987","volume":"76","author":"H Hengel","year":"1995","unstructured":"Hengel H, Esslinger C, Pool J et al (1995) Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol 76(Pt 12):2987\u20132997","journal-title":"J Gen Virol"},{"key":"457_CR42","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/JVI.53.2.684-690.1985","volume":"53","author":"S Rozenblatt","year":"1985","unstructured":"Rozenblatt S, Eizenberg O, Ben-Levy R et al (1985) Sequence homology within the morbilliviruses. J Virol 53:684\u2013690","journal-title":"J Virol"},{"key":"457_CR43","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/j.1365-2362.2007.01881.x","volume":"37","author":"K Hoetzenecker","year":"2007","unstructured":"Hoetzenecker K, Hacker S, Hoetzenecker W et al (2007) Cytomegalovirus hyperimmunoglobulin: mechanisms in allo-immune response in vitro. Eur J Clin Invest 37:978\u2013986. doi: 10.1111\/j.1365-2362.2007.01881.x","journal-title":"Eur J Clin Invest"},{"key":"457_CR44","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJMoa043337","volume":"353","author":"G Nigro","year":"2005","unstructured":"Nigro G, Adler SP, La Torre R, Best AM (2005) Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353:1350\u20131362. doi: 10.1056\/NEJMoa043337","journal-title":"N Engl J Med"},{"key":"457_CR45","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1056\/NEJM198710223171703","volume":"317","author":"DR Snydman","year":"1987","unstructured":"Snydman DR, Werner BG, Heinze-Lacey B et al (1987) Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med 317:1049\u20131054. doi: 10.1056\/NEJM198710223171703","journal-title":"N Engl J Med"},{"key":"457_CR46","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jcv.2006.12.017","volume":"38","author":"A Tischer","year":"2007","unstructured":"Tischer A, Gassner M, Richard J-L et al (2007) Vaccinated students with negative enzyme immunoassay results show positive measles virus-specific antibody levels by immunofluorescence and plaque neutralisation tests. J Clin Virol 38:204\u2013209. doi: 10.1016\/j.jcv.2006.12.017","journal-title":"J Clin Virol"},{"key":"457_CR47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1479-5868-6-50","volume":"6","author":"B Bringolf-Isler","year":"2009","unstructured":"Bringolf-Isler B, Grize L, M\u00e4der U et al (2009) Assessment of intensity, prevalence and duration of everyday activities in Swiss school children: a cross-sectional analysis of accelerometer and diary data. Int J Behav Nutr Phys Act 6:50. doi: 10.1186\/1479-5868-6-50","journal-title":"Int J Behav Nutr Phys Act"},{"key":"457_CR48","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1099\/vir.0.013524-0","volume":"90","author":"T Finsterbusch","year":"2009","unstructured":"Finsterbusch T, Wolbert A, Deitemeier I et al (2009) Measles viruses of genotype H1 evade recognition by vaccine-induced neutralizing antibodies targeting the linear haemagglutinin noose epitope. J Gen Virol 90:2739\u20132745. doi: 10.1099\/vir.0.013524-0","journal-title":"J Gen Virol"},{"key":"457_CR49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0166-0934(86)90005-4","volume":"14","author":"E Gonczol","year":"1986","unstructured":"Gonczol E, Furlini G, Ianacone J, Plotkin SA (1986) A rapid microneutralization assay for cytomegalovirus. J Virol Methods 14:37\u201341","journal-title":"J Virol Methods"},{"key":"457_CR50","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1099\/vir.0.80467-0","volume":"86","author":"S Santibanez","year":"2005","unstructured":"Santibanez S, Niewiesk S, Heider A et al (2005) Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies? J Gen Virol 86:365\u2013374. doi: 10.1099\/vir.0.80467-0","journal-title":"J Gen Virol"},{"key":"457_CR51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0264-410X(94)90049-3","volume":"12","author":"B Christenson","year":"1994","unstructured":"Christenson B, B\u00f6ttiger M (1994) Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine 12:129\u2013133","journal-title":"Vaccine"},{"key":"457_CR52","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1099\/0022-1317-83-11-2699","volume":"83","author":"S Santibanez","year":"2002","unstructured":"Santibanez S, Tischer A, Heider A et al (2002) Rapid replacement of endemic measles virus genotypes. J Gen Virol 83:2699\u20132708","journal-title":"J Gen Virol"},{"key":"457_CR53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0166-0934(81)90062-8","volume":"3","author":"P Albrecht","year":"1981","unstructured":"Albrecht P, Herrmann K, Burns GR (1981) Role of virus strain in conventional and enhanced measles plaque neutralization test. J Virol Methods 3:251\u2013260","journal-title":"J Virol Methods"},{"key":"457_CR54","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JCM.33.4.811-815.1995","volume":"33","author":"S Ratnam","year":"1995","unstructured":"Ratnam S, Gadag V, West R et al (1995) Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody. J Clin Microbiol 33:811\u2013815","journal-title":"J Clin Microbiol"},{"key":"457_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.coviro.2012.01.001","volume":"2","author":"AL Vanarsdall","year":"2012","unstructured":"Vanarsdall AL, Johnson DC (2012) Human cytomegalovirus entry into cells. Curr Opin Virol 2:37\u201342. doi: 10.1016\/j.coviro.2012.01.001","journal-title":"Curr Opin Virol"},{"key":"457_CR56","doi-asserted-by":"publisher","first-page":"10960","DOI":"10.1128\/JVI.78.20.10960-10966.2004","volume":"78","author":"SM Varnum","year":"2004","unstructured":"Varnum SM, Streblow DN, Monroe ME et al (2004) Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol 78:10960\u201310966. doi: 10.1128\/JVI.78.20.10960-10966.2004","journal-title":"J Virol"},{"key":"457_CR57","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.cell.2014.04.028","volume":"157","author":"MP Weekes","year":"2014","unstructured":"Weekes MP, Tomasec P, Huttlin EL et al (2014) Quantitative temporal viromics: an approach to investigate host-pathogen interaction. Cell 157:1460\u20131472. doi: 10.1016\/j.cell.2014.04.028","journal-title":"Cell"},{"key":"457_CR58","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1126\/science.1227919","volume":"338","author":"N Stern-Ginossar","year":"2012","unstructured":"Stern-Ginossar N, Weisburd B, Michalski A et al (2012) Decoding human cytomegalovirus. Science 338:1088\u20131093. doi: 10.1126\/science.1227919","journal-title":"Science"},{"key":"457_CR59","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jcv.2011.06.018","volume":"52","author":"E Genini","year":"2011","unstructured":"Genini E, Percivalle E, Sarasini A et al (2011) Serum antibody response to the gH\/gL\/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections. J Clin Virol 52:113\u2013118. doi: 10.1016\/j.jcv.2011.06.018","journal-title":"J Clin Virol"},{"key":"457_CR60","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3390\/v7031113","volume":"7","author":"IH Haralambieva","year":"2015","unstructured":"Haralambieva IH, Simon WL, Kennedy RB et al (2015) Profiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays. Viruses 7:1113\u20131133. doi: 10.3390\/v7031113","journal-title":"Viruses"},{"key":"457_CR61","doi-asserted-by":"publisher","first-page":"11547","DOI":"10.1128\/JVI.79.17.11547-11551.2005","volume":"79","author":"RL Swart de","year":"2005","unstructured":"de Swart RL, Y\u00fcksel S, Osterhaus ADME (2005) Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization. J Virol 79:11547\u201311551. doi: 10.1128\/JVI.79.17.11547-11551.2005","journal-title":"J Virol"},{"key":"457_CR62","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1135710","volume":"315","author":"S Roche","year":"2007","unstructured":"Roche S, Rey FA, Gaudin Y, Bressanelli S (2007) Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G. Science 315:843\u2013848. doi: 10.1126\/science.1135710","journal-title":"Science"},{"key":"457_CR63","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3390\/v4091731","volume":"4","author":"M Nicasio","year":"2012","unstructured":"Nicasio M, Sautto G, Clementi N et al (2012) Neutralization interfering antibodies: a \u201cNovel\u201d example of humoral immune dysfunction facilitating viral escape? Viruses 4:1731\u20131752. doi: 10.3390\/v4091731","journal-title":"Viruses"},{"key":"457_CR64","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/intimm\/dxg036","volume":"15","author":"M Oda","year":"2003","unstructured":"Oda M, Kozono H, Morii H, Azuma T (2003) Evidence of allosteric conformational changes in the antibody constant region upon antigen binding. Int Immunol 15:417\u2013426. doi: 10.1093\/intimm\/dxg036","journal-title":"Int Immunol"},{"key":"457_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00022","author":"A Janda","year":"2016","unstructured":"Janda A, Bowen A, Greenspan NS, Casadevall A (2016) Ig constant region effects on variable region structure and function. Front Microbiol. doi: 10.3389\/fmicb.2016.00022","journal-title":"Front Microbiol"},{"key":"457_CR66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.vaccine.2007.10.046","volume":"26","author":"BJ Cohen","year":"2007","unstructured":"Cohen BJ, Audet S, Andrews N, Beeler J (2007) Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine 26:59\u201366. doi: 10.1016\/j.vaccine.2007.10.046","journal-title":"Vaccine"},{"key":"457_CR67","doi-asserted-by":"publisher","first-page":"6143","DOI":"10.1182\/blood-2010-11-320317","volume":"117","author":"D Kim","year":"2011","unstructured":"Kim D, Huey D, Oglesbee M, Niewiesk S (2011) Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies. Blood 117:6143\u20136151. doi: 10.1182\/blood-2010-11-320317","journal-title":"Blood"},{"key":"457_CR68","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1128\/JVI.01476-07","volume":"82","author":"ER Sprague","year":"2008","unstructured":"Sprague ER, Reinhard H, Cheung EJ et al (2008) The human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin G. J Virol 82:3490\u20133499. doi: 10.1128\/JVI.01476-07","journal-title":"J Virol"},{"key":"457_CR69","doi-asserted-by":"crossref","first-page":"8596","DOI":"10.1128\/JVI.76.17.8596-8608.2002","volume":"76","author":"R Atalay","year":"2002","unstructured":"Atalay R, Zimmermann A, Wagner M et al (2002) Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol 76:8596\u20138608","journal-title":"J Virol"},{"key":"457_CR70","doi-asserted-by":"publisher","first-page":"e1004131","DOI":"10.1371\/journal.ppat.1004131","volume":"10","author":"E Corrales-Aguilar","year":"2014","unstructured":"Corrales-Aguilar E, Trilling M, Hunold K et al (2014) Human cytomegalovirus Fc\u03b3 binding proteins gp34 and gp68 antagonize Fc\u03b3 receptors I, II and III. PLoS Pathog 10:e1004131. doi: 10.1371\/journal.ppat.1004131","journal-title":"PLoS Pathog"},{"key":"457_CR71","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00281-014-0448-2","volume":"36","author":"E Corrales-Aguilar","year":"2014","unstructured":"Corrales-Aguilar E, Hoffmann K, Hengel H (2014) CMV-encoded Fc\u03b3 receptors: modulators at the interface of innate and adaptive immunity. Semin Immunopathol 36:627\u2013640. doi: 10.1007\/s00281-014-0448-2","journal-title":"Semin Immunopathol"},{"key":"457_CR72","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","volume":"329","author":"JR Groothuis","year":"1993","unstructured":"Groothuis JR, Simoes EA, Levin MJ et al (1993) Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med 329:1524\u20131530. doi: 10.1056\/NEJM199311183292102","journal-title":"N Engl J Med"},{"key":"457_CR73","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nm833","volume":"9","author":"RS Veazey","year":"2003","unstructured":"Veazey RS, Shattock RJ, Pope M et al (2003) Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat Med 9:343\u2013346. doi: 10.1038\/nm833","journal-title":"Nat Med"},{"key":"457_CR74","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jcv.2005.06.004","volume":"35","author":"B Ludwig","year":"2006","unstructured":"Ludwig B, Kraus FB, Kipp M et al (2006) Cytomegalovirus-specific CD4 T-cell and glycoprotein B specific antibody response in recipients of allogenic stem cell transplantation. J Clin Virol 35:160\u2013166. doi: 10.1016\/j.jcv.2005.06.004","journal-title":"J Clin Virol"},{"key":"457_CR75","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jmv.2004","volume":"65","author":"I Mu\u00f1oz","year":"2001","unstructured":"Mu\u00f1oz I, Guti\u00e9rrez A, Gimeno C et al (2001) Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant. J Med Virol 65:77\u201384","journal-title":"J Med Virol"},{"key":"457_CR76","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/0264-410X(95)00060-E","volume":"13","author":"RL Ward","year":"1995","unstructured":"Ward RL, Bernstein DI (1995) Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group. Vaccine 13:1226\u20131232","journal-title":"Vaccine"},{"key":"457_CR77","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06054","author":"C Petro","year":"2015","unstructured":"Petro C, Gonz\u00e1lez PA, Cheshenko N et al (2015) Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease. Elife. doi: 10.7554\/eLife.06054","journal-title":"Elife"},{"key":"457_CR78","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/74704","volume":"6","author":"RA Clynes","year":"2000","unstructured":"Clynes RA, Towers TL, Presta LG, Ravetch JV (2000) Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat Med 6:443\u2013446. doi: 10.1038\/74704","journal-title":"Nat Med"},{"key":"457_CR79","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1126\/science.1118948","volume":"310","author":"F Nimmerjahn","year":"2005","unstructured":"Nimmerjahn F, Ravetch JV (2005) Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310:1510\u20131512. doi: 10.1126\/science.1118948","journal-title":"Science"},{"key":"457_CR80","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1128\/JVI.01943-06","volume":"81","author":"DB Lowe","year":"2007","unstructured":"Lowe DB, Shearer MH, Jumper CA et al (2007) Fc gamma receptors play a dominant role in protective tumor immunity against a virus-encoded tumor-specific antigen in a murine model of experimental pulmonary metastases. J Virol 81:1313\u20131318. doi: 10.1128\/JVI.01943-06","journal-title":"J Virol"},{"key":"457_CR81","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1126\/science.1129594","volume":"313","author":"Y Kaneko","year":"2006","unstructured":"Kaneko Y, Nimmerjahn F, Ravetch JV (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313:670\u2013673. doi: 10.1126\/science.1129594","journal-title":"Science"},{"key":"457_CR82","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.immuni.2006.11.010","volume":"26","author":"K-H Park-Min","year":"2007","unstructured":"Park-Min K-H, Serbina NV, Yang W et al (2007) FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin. Immunity 26:67\u201378. doi: 10.1016\/j.immuni.2006.11.010","journal-title":"Immunity"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-016-0457-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-016-0457-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-016-0457-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T03:47:30Z","timestamp":1692330450000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-016-0457-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["457"],"URL":"https:\/\/doi.org\/10.1007\/s00430-016-0457-y","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,18]]}}}